Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12533712rdf:typepubmed:Citationlld:pubmed
pubmed-article:12533712lifeskim:mentionsumls-concept:C1622968lld:lifeskim
pubmed-article:12533712lifeskim:mentionsumls-concept:C0019143lld:lifeskim
pubmed-article:12533712lifeskim:mentionsumls-concept:C0221284lld:lifeskim
pubmed-article:12533712lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:12533712lifeskim:mentionsumls-concept:C1136102lld:lifeskim
pubmed-article:12533712lifeskim:mentionsumls-concept:C0162326lld:lifeskim
pubmed-article:12533712lifeskim:mentionsumls-concept:C1706211lld:lifeskim
pubmed-article:12533712lifeskim:mentionsumls-concept:C0086597lld:lifeskim
pubmed-article:12533712lifeskim:mentionsumls-concept:C1517499lld:lifeskim
pubmed-article:12533712lifeskim:mentionsumls-concept:C0205410lld:lifeskim
pubmed-article:12533712pubmed:issuePt 1lld:pubmed
pubmed-article:12533712pubmed:dateCreated2003-1-20lld:pubmed
pubmed-article:12533712pubmed:abstractTextUsing synthetic peptides we have shown that positively charged sequences present at the C terminus of the L1 protein and the N and C termini of the L2 protein of human papillomavirus type 16 (HPV-16) bind to both DNA and heparan sulfate receptors. Moreover, these short amino acid sequences are sufficient to mediate gene transfer in COS-7 cells. The L1 proteins of other HPVs were shown to contain one or two DNA- and heparin-binding sequences that have the capacity to transfer genes. These DNA-binding sequences also recognized the enhancing packaging sequence of bovine papillomavirus type 1. The results suggest that the L2 protein could participate in DNA packaging during maturation of virions.lld:pubmed
pubmed-article:12533712pubmed:languageenglld:pubmed
pubmed-article:12533712pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12533712pubmed:citationSubsetIMlld:pubmed
pubmed-article:12533712pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12533712pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12533712pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12533712pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12533712pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12533712pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12533712pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12533712pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12533712pubmed:statusMEDLINElld:pubmed
pubmed-article:12533712pubmed:monthJanlld:pubmed
pubmed-article:12533712pubmed:issn0022-1317lld:pubmed
pubmed-article:12533712pubmed:authorpubmed-author:TouzéAntoineAlld:pubmed
pubmed-article:12533712pubmed:authorpubmed-author:CoursagetPier...lld:pubmed
pubmed-article:12533712pubmed:authorpubmed-author:BousarghinLat...lld:pubmed
pubmed-article:12533712pubmed:authorpubmed-author:Combita-Rojas...lld:pubmed
pubmed-article:12533712pubmed:issnTypePrintlld:pubmed
pubmed-article:12533712pubmed:volume84lld:pubmed
pubmed-article:12533712pubmed:ownerNLMlld:pubmed
pubmed-article:12533712pubmed:authorsCompleteYlld:pubmed
pubmed-article:12533712pubmed:pagination157-64lld:pubmed
pubmed-article:12533712pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12533712pubmed:meshHeadingpubmed-meshheading:12533712...lld:pubmed
pubmed-article:12533712pubmed:meshHeadingpubmed-meshheading:12533712...lld:pubmed
pubmed-article:12533712pubmed:meshHeadingpubmed-meshheading:12533712...lld:pubmed
pubmed-article:12533712pubmed:meshHeadingpubmed-meshheading:12533712...lld:pubmed
pubmed-article:12533712pubmed:meshHeadingpubmed-meshheading:12533712...lld:pubmed
pubmed-article:12533712pubmed:meshHeadingpubmed-meshheading:12533712...lld:pubmed
pubmed-article:12533712pubmed:meshHeadingpubmed-meshheading:12533712...lld:pubmed
pubmed-article:12533712pubmed:meshHeadingpubmed-meshheading:12533712...lld:pubmed
pubmed-article:12533712pubmed:meshHeadingpubmed-meshheading:12533712...lld:pubmed
pubmed-article:12533712pubmed:meshHeadingpubmed-meshheading:12533712...lld:pubmed
pubmed-article:12533712pubmed:meshHeadingpubmed-meshheading:12533712...lld:pubmed
pubmed-article:12533712pubmed:meshHeadingpubmed-meshheading:12533712...lld:pubmed
pubmed-article:12533712pubmed:meshHeadingpubmed-meshheading:12533712...lld:pubmed
pubmed-article:12533712pubmed:meshHeadingpubmed-meshheading:12533712...lld:pubmed
pubmed-article:12533712pubmed:meshHeadingpubmed-meshheading:12533712...lld:pubmed
pubmed-article:12533712pubmed:meshHeadingpubmed-meshheading:12533712...lld:pubmed
pubmed-article:12533712pubmed:meshHeadingpubmed-meshheading:12533712...lld:pubmed
pubmed-article:12533712pubmed:meshHeadingpubmed-meshheading:12533712...lld:pubmed
pubmed-article:12533712pubmed:year2003lld:pubmed
pubmed-article:12533712pubmed:articleTitlePositively charged sequences of human papillomavirus type 16 capsid proteins are sufficient to mediate gene transfer into target cells via the heparan sulfate receptor.lld:pubmed
pubmed-article:12533712pubmed:affiliationLaboratoire de Virologie Moléculaire, INSERM EMIU 00-10 and USC INRA, Faculté des Sciences Pharmaceutiques 'Philippe Maupas', 31 avenue Monge, 37200 Tours, France.lld:pubmed
pubmed-article:12533712pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12533712pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12533712lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12533712lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12533712lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12533712lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12533712lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12533712lld:pubmed